Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆
David R. Spigel, David Vicente, Tudor–Eliade Ciuleanu, Scott Gettinger, Solange Peters, Leora Horn, Clarisse Audigier-Valette, N. Pardo Aranda, Óscar Juan, Ying Cheng, H. Zhang, Meiqi Shi, Alexander Luft, Juergen Wolf, Scott Antonia, Kazuhiko Nakagawa, Justin Fairchild, Christine Baudelet, Devangini K. Pandya, Parul Doshi, Han Chang, Martin Reck
Topics & Concepts
MedicineNivolumabInternal medicineHazard ratioLung cancerChemotherapyOncologyClinical endpointGemcitabineRandomized controlled trialGastroenterologyConfidence intervalCancerSurgeryImmunotherapyLung Cancer Research StudiesCancer Immunotherapy and BiomarkersBrain Metastases and Treatment